Study of ARC-520 With or Without Other Drugs Used in the Treatment of Chronic Chronic Hepatitis B Virus (HBV)
Trial details
- Registry ID
- NCT02577029
- Phase
- Phase 2
Drug identity checked against registry records
Also recorded as Pegasys; Peginterferon
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| Study of ARC-520 With or Without Other Drugs Used in the Treatment of Chronic Chronic Hepatitis B Virus (HBV)NCT02577029 | Arrowhead Pharmaceuticals | Phase 2 | Terminated | 2016-12Actual |
| No regulatory events match this view.This does not mean no FDA events have occurred. |